Preclinical characterization of a potential best-in-class camptothecin-based antibody-drug conjugate targeting ADAM metallopeptidase domain 9
科學論文
Serplulimab in combination with regorafenib and hepatic artery bicarbonate infusion on the third-line treatment in advanced colorectal cancer patients with liver metastasis: study protocol of a single-arm, single-center phase II study
CSCO 2024
First-Line Serplulimab for Advanced Squamous Non-Small Cell Lung Cancer: A Multicenter, Single-Arm, Real-World ASTRUM-004R Study
ESMO Aisa 2024
Is neoadjuvant chemoimmunotherapy better than chemotherapy in patients with limited-stage small cell lung cancer: a retrospective comparative study
WCLC 2024
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer: The Multicenter ASTRUM-005R Study
WCLC 2024
Perioperative serplulimab and chemotherapy in patients with resectable squamous non-small cell lung cancer: an open-label, single-arm, phase 2 trial
ESMO 2024
Efficacy and Safety of Integrating Consolidative Thoracic Radiotherapy with Immunochemotherapy in ES-SCLC: A Real-world Retrospective Analysis
